Cargando…

Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens

Intestinal microbiome changes that occur in HIV positive individuals on different antiretroviral therapy (ART) regimens are important to understand, as they are potentially linked with chronic inflammation and microbiome-linked comorbidities that occur at increased incidence in this population. We c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinto-Cardoso, Sandra, Lozupone, Catherine, Briceño, Olivia, Alva-Hernández, Selma, Téllez, Norma, Adriana, Aguilar, Murakami-Ogasawara, Akio, Reyes-Terán, Gustavo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338340/ https://www.ncbi.nlm.nih.gov/pubmed/28262770 http://dx.doi.org/10.1038/srep43741

Ejemplares similares

Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment
por: Briceño, Olivia, et al.
Publicado: (2016)

Associations between recent thymic emigrants and CD4(+) T-cell recovery after short-term antiretroviral therapy initiation
por: Briceño, Olivia, et al.
Publicado: (2020)

The vaginal microbiota of women living with HIV on suppressive antiretroviral therapy and its relation to high-risk human papillomavirus infection
por: Chávez-Torres, Monserrat, et al.
Publicado: (2023)

Impact of antiretroviral drugs on the microbiome: unknown answers to important questions
por: Pinto-Cardoso, Sandra, et al.
Publicado: (2018)

Mucosal immune cell populations and the bacteriome of adenoids and tonsils from people living with HIV on suppressive antiretroviral therapy
por: Briceño, Olivia, et al.
Publicado: (2022)

Longitudinal variation in human immunodeficiency virus long terminal repeat methylation in individuals on suppressive antiretroviral therapy
por: Cortés-Rubio, César N., et al.
Publicado: (2019)

Alteration of the gut fecal microbiome in children living with HIV on antiretroviral therapy in Yaounde, Cameroon
por: Abange, William Baiye, et al.
Publicado: (2021)

Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico
por: Soto-Nava, Maribel, et al.
Publicado: (2018)

Distinct fecal microbial signatures are linked to sex and chronic immune activation in pediatric HIV infection
por: Rosel-Pech, Cecilia, et al.
Publicado: (2023)

Prevalence and Source of Fecal and Oral Bacteria on Infant, Child, and Adult Hands
por: Shaffer, Michael, et al.
Publicado: (2018)

Influence of quinacrine and chloroquine on the in vitro 3′-azido-3′-deoxythymidine antiretroviral effect
por: Torres, Klintsy J, et al.
Publicado: (2015)

Antiretroviral regimen complexity as a predictor of adherence
por: Boyle, C, et al.
Publicado: (2010)

Comparison of Antiretroviral Regimens: Adverse Effects and Tolerability Failure that Cause Regimen Switching
por: Kim, Min Jung, et al.
Publicado: (2015)

Central Nervous System Strongyloidiasis and Cryptococcosis in an HIV-Infected Patient Starting Antiretroviral Therapy
por: Rodríguez, Mónica, et al.
Publicado: (2012)

Effectiveness of antiretroviral therapy in the single-tablet regimen era
por: Costa, Juliana de Oliveira, et al.
Publicado: (2018)

Towards an ideal antiretroviral regimen for the global HIV epidemic
por: Grinsztejn, Beatriz, et al.
Publicado: (2017)

Designing a Predictive Model for Antiretroviral Regimen at the Antiretroviral Therapy Center in Chiro Hospital, Ethiopia
por: Nemomsa, Gadissa, et al.
Publicado: (2021)

Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected Individuals
por: Blanco-Heredia, Juan, et al.
Publicado: (2016)

Correction: Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected Individuals
por: Blanco-Heredia, Juan, et al.
Publicado: (2016)

Dosing Regimen of Enrofloxacin Impacts Intestinal Pharmacokinetics and the Fecal Microbiota in Steers
por: Ferguson, Kaitlyn M., et al.
Publicado: (2018)

Effects of danofloxacin dosing regimen on gastrointestinal pharmacokinetics and fecal microbiome in steers
por: Halleran, J. L., et al.
Publicado: (2021)

Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
por: Vilaplana, Vicente Escudero, et al.
Publicado: (2010)

Medication Possession Ratio Predicts Antiretroviral Regimens Persistence in Peru
por: Salinas, Jorge L., et al.
Publicado: (2013)

Effectiveness of four antiretroviral regimens for treating people living with HIV
por: Cavalcanti, Aracele Tenório de Almeida e, et al.
Publicado: (2020)

The fecal bacterial microbiota of bats; Slovenia
por: Vengust, Modest, et al.
Publicado: (2018)

HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy
por: Avila-Ríos, Santiago, et al.
Publicado: (2015)

Suppression of HIV in the first 12 months of antiretroviral therapy: a comparative analysis of dolutegravir- and efavirenz-based regimens
por: da Silva, Gabriella Jomara, et al.
Publicado: (2023)

Patient and Regimen Characteristics Associated with Self-Reported Nonadherence to Antiretroviral Therapy
por: Sullivan, Patrick S., et al.
Publicado: (2007)

Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort
por: Chua, Arlene C, et al.
Publicado: (2012)

Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens
por: Philippe Küpper-Tetzel, Claus, et al.
Publicado: (2014)

Incidence and Predictors of First Line Antiretroviral Regimen Modification in Western Kenya
por: Inzaule, Seth, et al.
Publicado: (2014)

1009. Dolutegravir and Doravirine in Combination: When Standard Antiretroviral Regimens are Unacceptable
por: Denyer, Rachel, et al.
Publicado: (2020)

1133 Consequences of Late Presentation for HIV Care in Mexico, 2007-2013
por: Zamboni, Daniela De La Rosa, et al.
Publicado: (2014)

Nuke-sparing regimens as a main simplification strategy and high level of toxicity resolution after antiretroviral switch: the SWITCHART Study
por: Carrero-Gras, Ana, et al.
Publicado: (2014)

Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age
por: Torres, Thiago Silva, et al.
Publicado: (2013)

Differences in Lipid Measurements by Antiretroviral Regimen Exposure in Cohorts from Asia and Australia
por: Achhra, Amit C., et al.
Publicado: (2012)

Efavirenz Conceptions and Regimen Management in a Prospective Cohort of Women on Antiretroviral Therapy
por: Schwartz, Sheree, et al.
Publicado: (2012)

Evaluation of the adverse reactions of antiretroviral drug regimens in a tertiary care hospital
por: Rather, Zahoor A., et al.
Publicado: (2013)

Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
por: Bîstrițchi, Ina, et al.
Publicado: (2013)

Impact of adverse events of antiretroviral treatment on regimen change and mortality in Ugandan children
por: Malangu, Ntambwe, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_rd0c45ivbjeefhohpl5vb9h1de